Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Specific Clinical Experience Investigation for Long-term Use of Bydureon Subcutaneous Injection 2 mg and Bydureon Subcutaneous Injection 2 mg PEN

NCT01940770 is registered in ClinicalTrials.gov with AstraZeneca as lead sponsor.

NCT NCT01940770
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01940770 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Specific Clinical Experience Investigation for Long-term Use of Bydureon Subcutaneous Injection 2 mg and Bydureon Subcutaneous Injection 2 mg PEN
Lead sponsor
AstraZeneca
Phase
Observational
Overall status
Completed
Start date
October 18, 2013
Completion date
November 29, 2019
Enrollment
1,137 (actual)
Sites
47

Conditions

As the registry lists them; a condition with its own page is linked.

type 2 diabetes